Northern Trust Corp Decreases Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Northern Trust Corp cut its holdings in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 5.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 598,929 shares of the biotechnology company’s stock after selling 32,283 shares during the quarter. Northern Trust Corp owned 0.80% of Axon Enterprise worth $154,721,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. BKM Wealth Management LLC purchased a new stake in Axon Enterprise during the fourth quarter worth $32,000. Key Financial Inc boosted its position in Axon Enterprise by 367.6% during the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after purchasing an additional 125 shares in the last quarter. Lindbrook Capital LLC boosted its position in Axon Enterprise by 43.3% during the fourth quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after purchasing an additional 52 shares in the last quarter. Rakuten Securities Inc. purchased a new stake in Axon Enterprise during the fourth quarter worth $48,000. Finally, Principal Securities Inc. purchased a new stake in Axon Enterprise during the fourth quarter worth $49,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In related news, Director Jeri Williams sold 308 shares of the stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the transaction, the director now owns 1,607 shares of the company’s stock, valued at $498,282.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Jeri Williams sold 308 shares of the stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the transaction, the director now owns 1,607 shares of the company’s stock, valued at $498,282.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Joshua Isner sold 44,000 shares of the stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $309.96, for a total value of $13,638,240.00. Following the completion of the transaction, the president now directly owns 275,843 shares of the company’s stock, valued at approximately $85,500,296.28. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 89,447 shares of company stock valued at $27,684,677. Insiders own 5.70% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on AXON shares. Needham & Company LLC reiterated a “buy” rating and set a $400.00 target price on shares of Axon Enterprise in a research report on Tuesday, May 7th. Robert W. Baird boosted their price target on Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a report on Thursday, February 22nd. Craig Hallum boosted their price target on Axon Enterprise from $325.00 to $370.00 and gave the stock a “buy” rating in a report on Tuesday, May 7th. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a report on Wednesday, April 24th. Finally, Barclays boosted their price target on Axon Enterprise from $308.00 to $381.00 and gave the stock an “overweight” rating in a report on Wednesday, May 8th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $335.27.

View Our Latest Report on AXON

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $285.40 on Tuesday. Axon Enterprise, Inc. has a 1-year low of $175.37 and a 1-year high of $329.87. The business has a 50-day moving average of $299.72 and a 200-day moving average of $278.96. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.91 and a quick ratio of 2.55. The company has a market capitalization of $21.54 billion, a price-to-earnings ratio of 83.45 and a beta of 0.91.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.20. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The company had revenue of $460.74 million during the quarter, compared to the consensus estimate of $441.57 million. During the same quarter in the prior year, the business earned $0.51 earnings per share. The company’s revenue was up 34.3% compared to the same quarter last year. On average, equities analysts anticipate that Axon Enterprise, Inc. will post 2.35 EPS for the current fiscal year.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.